期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

海洋抗肿瘤环酯肽的研究进展 被引量：1

Research Development of Antitumoral Cyclodepsipeptides from Marine Resources
在线阅读 下载PDF
导出
摘要 对来自海洋微生物、海绵动物、软体动物、尾索动物中的抗肿瘤环酯肽的研究进展进行了综述,并对该领域未来的研究重点进行了展望。 The latest research advances on antitumoral cyclodepsipeptides from marine microorganisms,sponges,mollusks and ascidians were reviewed in this paper,and the main prospects in this field for further research in the future were proposed.
作者 魏婷婷 李琳 李海亮 任锦 钦传光
机构地区 西北工业大学生命学院
出处 《化学与生物工程》 CAS 2011年第5期1-6,共6页 Chemistry & Bioengineering
基金 国家自然科学基金资助项目(20672086 20802057) 国家人事部回国留学人员科技基金资助项目(国人厅发[2007]170号) 西北工业大学基础科研基金资助项目(JC200824) 西北工业大学研究生创业种子基金资助项目(Z2010027)
关键词 环酯肽 抗肿瘤活性 海洋药物 海洋资源 天然产物 cyclodepsipeptide antitumoral activity marine drug marine resource natural product
分类号 TQ464 [化学工程—制药化工]
作者简介 魏婷婷（1985-），女，山东烟台人，硕士研究生，研究方向：多肽固相合成及生物活性筛选； 通讯作者：钦传光，教授。E-mail：qinchg@nwpu．edu．cn。
  • 相关文献

参考文献31

  • 1Luesch H,Yoshida W Y,Moore R E,et al.Total structure determination of apratoxin A,a potent novel cytotoxin from the marine cyanobacterium Lyngbya majuscuLa[J].Am Chem Soc,2001,123 (23):5418-5423.
  • 2Ma D W,Zou B,Cai G R,et al.Total synthesis of the cyclodepsipeptide apratoxin A and its analogues and assessment of their biological activities[J].Chem Eur,2006,12(29):7615-7626.
  • 3Shen S S,Zhang P T,Lovchik M A,et al.Cyclodepsipeptide toxin promotes the degradation of Hsp90 client proteins through chaperone-mediated autophagy[J].J Cell Biol,2009,185(4):629-639.
  • 4Luesch H,Yoshida W,Moore R,et al.New apratoxins of marine cyanobacterial origin from guam and palau[J].Bioorg Med Chem,2002,10(6):1973-1978.
  • 5Sugiyama H,Watanabe A,Teruya T,et al.Synthesis of palau'amide and its diastereomers:Confirmation of its stereostructure[J].Tetrahedron Lett,2009,50(52):7343-7345.
  • 6Xie W Q,Zou B,Pei D Q,et al.Total synthesis of cyclic tetrapeptide FR235222,a potent immunosuppressant that inhibits mammalian histone deacetylases[J].Org Lett.2005,7(13):2775-2777.
  • 7Matthew S,Ross C,Rocca J R,et al.Lyngbyastatin 4,a dolastatin 13 analogue with elastase and chymotrypsin inhibitory activity from the marine cyanobacterium Lyngbya confervoides[J].J Nat Prod,2007,70(1):124-127.
  • 8Matthew S,Paul V J,Luesch H.Tiglicamides A～C,cyclodepsipeptides from the marine cyanobacterium Lyngbya confervoides[J].Phytochemistry,2009,70(17-18):2058-2063.
  • 9Matthew S,Ross C,Paul V J,et al.Pompanopeptins A and B,new cyclic peptides from the marine cyanobactenum Lyngbya confervoides[J].Tetrahedron,2008,64(18):4081-4089.
  • 10Liu L,Rein K S.New peptides isolated from Lyngbya species:A review[J].Mar Drugs,2010,8(6):1817-1837.

二级参考文献72

  • 1孙雪文,邓洪渊,谭红.环肽的分析方法与研究[J].世界科技研究与发展,2005,27(4):72-78. 被引量：7
  • 2Verschraegen CF, Glover K. ET-743 (PharmaMar/NCI/Ortho Biotech) [J]. Curt Opin InvestinK DruKs, 2001, 2(11):1631.
  • 3Scotto KW. ET-743~ More than an innovative machanism of action[J]. Anticancer Drugs, 2002, 13 suppl 1 :S3.
  • 4Cvetkovic RS, Figgitt DP, Plosker GL. ET-743 [J].Drugs,2002,62(8) .- 1185.
  • 5Gajate CA. Mollinedo F. Differential cytostatic and apoptotic effects of ecteinascidin-743 in cancer cells. Transcriptiondependent cell cycle arrest and transcrlption-independent JNK and mitochondrial mediated apoptosis[J]. J Biol them, 2002,277(44) : 41580.
  • 6Michael V. Chemist Improves Synthesis of Scarce Drugs[R]. NIH Record, 2000.
  • 7Shengkan J, Barbara G, Glynn F, et al. Ecteinascidin 743, a transcription-targeted chemotherapeutic that inhibits MDR1 activation[J]. Proc Natl Acad Sci USA, 2000,97 (12) :6775.
  • 8Kesteren C, Cvitkovic E, Taarnma A, eta1. Pharmacokinetics and pharmacodynamics of the novel marine-derived anticancer agent ecteinaseidin 743 in a phase I dose-finding study[J]. Clin Cancer Res, 2000,6(12) :4725.
  • 9Taamma A, Misset JL, Riofrio M, ee al. Phase I and pharmacokinetic study of ecteinascidin-743, a new marine compound, administered as a 24-hour continuous infusion in patients with solid tumors[J]. J Clin Oncol, 2001,19(5) :1256.
  • 10Kesteren C, Twelves C, Bowman A, et al. Clinical pharmacology of the novel marine-derived anticancer agent Ecteinascidin 743 administered as a 1- and 3-h infusion in a phase I study[J]. Anticuncer Drugs ,2002 , 13(4) : 381.

共引文献7

同被引文献1

引证文献1

化学与生物工程
2011年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
关于我们 | 版权声明 | 联系我们 | 帮助中心| 意见反馈
主办单位：上海市教育委员会
技术支持：重庆维普资讯有限公司
渝公网安备 50019002500403号
使用帮助 返回顶部